MFDS — authorised 17 April 1998
- Marketing authorisation holder: ABBVIE
- Status: likely_approved
🇰🇷 Zemplar in South Korea
MFDS authorised Zemplar on 17 April 1998
Marketing authorisation
Zemplar in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Nephrology approved in South Korea
Frequently asked questions
Is Zemplar approved in South Korea?
Yes. MFDS authorised it on 17 April 1998.
Who is the marketing authorisation holder for Zemplar in South Korea?
ABBVIE holds the South Korean marketing authorisation.